Sima Jeha

Sima Jeha, MD

Member, St. Jude Faculty
Director, Leukemia / Lymphoma Developmental Therapeutics

Departments

Oncology

Divisions

Leukemia / Lymphoma

Contact Information

Sima Jeha, MD
Oncology
MS 260, Room C6064
St. Jude Children's Research Hospital
262 Danny Thomas Place
Memphis, TN 38105-3678
Email: sima.jeha@stjude.org
Phone: 901-595-3901
FAX: 901-521-9005

Education

MD - American University of Beirut, Lebanon


Honors & Awards


Research Interests


Selected Publications

Hunger SP, Baruchel A, Biondi A, Evans WE, Jeha S, Loh M, Moericke A, Pieters R, Relling MV, Schmiegelow K, Schrappe M, Silverman LB, Stanulla M, Valsecchi MG, Vora A, Pui CH. The thirteenth international childhood acute lymphoblastic leukemia workshop report: La Jolla, CA, USA, December 7-9, 2011. Pediatr Blood Cancer Sep 28, 2012. [Epub ahead of print]

Roberts KG, Morin RD, Zhang J, Hirst M, Zhao Y, Su X, Chen SC, Payne-Turner D, Churchman ML, Harvey RC, Chen X, Kassap C, Yan C, Becksfort J, Finney RP, Teachy DT, Maude SL, Tse K, Moore R, Jones S, Mungali K, Birol I, Edmonson MN, Yu Y, Buetow KE, Chen IM, Carroll WL, Wei L, Ma J, Kleppe M, Levine RL, Garcia-Manero G, Larsen E, Shah NP, Devidas M, Reaman G, Smith M, Paugh SW, Evans WE, Grupp SA, Jeha S, Pui CH, Gerhard DS, Downing JR, Willman CL, Loh M, Hunger SP, Marra MA, Mullighan CG. Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia. Cancer Cell 22(2):153-66, 2012. PMCID:PMC3422513

Muwakkit S, Al-Aridi C, Samra A, Saab R, Mahfouz RA, Farra C, Jeha S, Abboud MR. Implementation of an intensive risk-stratified treatment protocol for children and adolescents with acute lymphoblastic leukemia in Lebanon. Am J Hematol 87(7):678-83, 2012.

Pui CH, Pei D, Pappo AS, Howard SC, Cheng C, Sandlund JT, Furman WL, Ribeiro RC, Spunt SL, Rubnitz JE, Jeha S, Hudson MM, Kun LE, Merchant TE, Kocak M, Broniscer A, Metzger ML, Downing JR, Leung W, Evans WE, Gajjar A. Treatment outcomes in black and white children with cancer: Results from the SEER database and St Jude Children’s Research Hospital, 1992 through 2007. J Clin Oncol 30(16):205-12, 2012. PMCID:PMC3383176

Leung W, Pui CH, Coustan-Smith E, Yang J, Pei D, Gan K, Srinivasan A, Hartford C, Triplett BM, Dallas M, Pillai A, Shook D, Rubnitz JE, Sandlund JT, Jeha S, Inaba H, Ribeiro RC, Handgretinger R, Laver JH, Campana D. Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia. Blood 120(2):468-72, 2012. PMCID:PMC3398757

Liu C, Kawedia JD, Cheng C, Pei D, Fernandez CA, Cai X, Crews KR, Kaste SC, Panetta JC, Bowman WP, Jeha S, Sandlund JT, Evans WE, Pui CH, Relling MV. Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemia. Leukemia Apr 9, 2012. [Epub ahead of print]

Hijiya N, Thomson B, Isakoff M, Silverman L, Steinherz PG, Borowitz M, Kadota R, Cooper T, Shen V, Dahl G, Thottassery JV, Jeha S, Maloney K, Paul J, Barry E, Carroll WL, Gaynon PS. Phase II trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory/relapsed acute lymphoblastic leukemia. Blood 118(23):6043-9, 2011.

Elbahlawan LM, Morrison RR, Jeha S, Cheng C, Liu W, Fiser RT. Impact of neutrophil recovery on oxygenation in pediatric oncology patients with acute hypoxemic respiratory failure. J Pediatr Hematol Oncol 33(7):e296-9, 2011.

Inaba H, Bhojwani D, Pauley J, Pei D, Cheng C, Metzger ML, Howard SC, Rubnitz JE, Sandlund JT, Ribeiro RC, Leung W, Campana D, Pui CH, Jeha S. Combination chemotherapy with clofarabine, cyclophosphamide, and etoposide in children with refractory or relapsed haematological malignancies. Br J Haematol 156(2):275-9, 2012. PMCID: PMC3235268

Bhojwani D, Pei D, Sandlund JT, Jeha S, Ribeiro RC, Rubnitz JE, Raimondi SC, Shurtleff S, Onciu M, Cheng C, Coustan -Smith E, Bowman WP, Howard SC, Metzger ML, Inaba H, Leung W, Evans WE, Campana D, Relling MV, Pui CH. ETV6-RUNX1-positiveacute lymphoblastic leukemia: improved outcome with contemporary therapy. Leukemia 26:265-70, 2012. PMCID: PMC3345278

Al-Aridi C, Abboud MR, Saab R, Eid D, Jeha S, Chan AK, Muwakkit SA. Thrombosis in children with acute lymphoblastic leukemia treated at a tertiary care center in Lebanon: Revisiting the role of predictive models. Pediatr Hematol Oncol 28(8):676-81, 2011.

Sullivan E, Jeha S. 50 years ago in the Journal of Pediatrics: Chickenpox and Leukemia. The Journal of Pediatrics 158:783, 2011.

Brennan RC, Helton KJ, Pei D, Cheng C, Inaba H, Metzger ML, Howard SC, Rubnitz JE, Ribeiro RC, Sandlund JT, Jeha S, Pui CH, Bhojwani D. Spinal epidural lipomatosis in children with hematologic malignancies. Ann Hematol 90:1067-74, 2011. PMCID: PMC3169011

Pui CH, Campana D, Sandlund JT, Bhojwani D, Evans WE, Relling MV, Jeha S. Treatment of childhood acute lymphoblastic leukemia without cranial irradiation. Ann Hematol 90(Suppl 1):S61-3, 2011.

Anghelescu DL, Faughnan LG, Jeha S, Relling MV, Hinds PS, Sandlund JT, Cheng C, Pei D, Hankins G, Pauley JL, Pui CH. Neuropathic pain during treatment for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 57:1147-53, 2011. PMCID: PMC3136575

Elbahlawan L, Gaur AH, Furman W, Jeha S, Woods T, Norris A, Morrison RR. Severe H1N1-associated acute respiratory failure in immunocompromised children. Pediatr Blood Cancer 57:625-8, 2011.

Pui CH, Pei D, Campana D, Bowman WP, Sandlund JT, Kaste SC, Ribeiro RC, Rubnitz JE, Coustan-Smith E, Jeha S, Cheng C, Metzger ML, Bhojwani D, Inaba H, Raimondi SC, Onciu M, Howard SC, Leung W, Downing JR, Evans WE, Relling MV. Improved prognosis of older adolescents with acute lymphoblastic leukemia. J Clin Oncol 29:386-391, 2011. PMCID: PMC3058285

Rytting M, Ravandi F, Estey E, Cortes J, Faderl S, Garcia-Manero G, Jeha S, Ouzounian S, Pierce S, Kantarjian H. Intensively timed combination chemotherapy for the induction of adult patients with acute myeloid leukemia: long-term follow-up of a phase 2 study. Cancer 116:5272-5278, 2010.

Chen SH, Pei D, Yang W, Cheng C, Jeha S, Cox NJ, Evans WE, Pui CH, Relling MV. Genetic variations in GRIA1 on chromosome 5q33 related to asparaginase hypersensitivity. Clin Pharmacol Ther 88:191-196, 2010. PMCID: PMC3000799

Bonate PL, Cunningham CC, Gaynon P, Jeha S, Kadota R, Lam GN, Razzouk B, Rytting M, Steinherz P, Weitman S. Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer. Cancer Chemother Pharmacol 67:875-90, 2010.

Horton TM, Sposto R, Brown P , Reynolds PC, Hunger SP, Winick N , Raetz E, Carroll W, Arceci R, Borowitz M, Gaynon P, Gore L, Jeha S, Maurer B, Siegel SE, Biondi A, Kearns P, Narendran A, Silverman L, Smith M, Zwaan M, Whitlock J. Toxicity assessment of molecularly targeted drugs incorporated into multiagent chemotherapy regimens for pediatric acute lymphocytic leukemia (ALL): review from an international consensus conference. Pediatr Blood Cancer 54:872-878, 2010. PMCID: PMC2857540

Pui CH, Pei D, Sandlund JT, Ribeiro RC, Rubnitz JE, Raimondi SC, Onciu M, Campana D, Kun LE, Jeha S, Cheng C, Howard SC, Metzger ML, Bhojwani D, Downing JR, Evans WE, Relling MV. Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia. Leukemia 24:371-382, 2010. PMCID: PMC2820159

Crews K, Zhou Y, Pauley J, Howard S, Jeha S, Relling M, Pui CH. Effect of allopurinol versus urate oxidase on methotrexate pharmacokinetics in children with newly diagnosed acute lymphoblastic leukemia. Cancer 116:227-232, 2010. PMCID: PMC2846832

Last update: February 2013